Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

KRX:007570 Revenue

Ilyang Pharmaceutical Co.,Ltd had revenue of 65.14B KRW in the quarter ending June 30, 2026, with 3.90% growth. This brings the company's total for the last twelve months to 277.96B, up 0.65% year-over-year. In the year 2025, Ilyang Pharmaceutical Co.,Ltd had annual revenue of 272.42B with 1.39% growth. That makes Ilyang Pharmaceutical Co.,Ltd the 17,366th largest company in the world by revenue and 880th in South Korea.

• Revenue (ttm): 277.96B
• Revenue Growth: +0.65%
• P/S Ratio: 0.43
• Revenue / Employee: 421.15M
• Employees: 660
• Market Cap: 119.38B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 222.81B 81.8%
• Overseas 49.61B 18.2%

Fiscal year ended Dec 31, 2025 See the full KRX:007570 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	272.42B	3.74B	1.39%
Dec 31, 2024	268.68B	2.01B	0.75%
Dec 31, 2023	266.67B	18.90B	7.63%
Dec 31, 2022	247.77B	5.26B	2.17%
Dec 31, 2021	242.51B	-100.82B	-29.36%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error